Label: NASOCLENZ- benzalkonium chloride 0.13% gel

  • NDC Code(s): 81900-013-01, 81900-013-02, 81900-013-03, 81900-013-04, view more
    81900-013-05, 81900-013-06, 81900-013-60, 81900-014-03, 81900-014-04, 81900-014-05, 81900-014-06
  • Packager: Silicon Valley Innovations, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated February 8, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • NasoClenz Cleansing Kit Drug Facts

  • Active Ingredient

    Benzalkonium chloride (0.13%)

  • Uses

    • Helps reduce bacteria that can cause skin infections
  • INDICATIONS & USAGE

    • Antiseptic preparation to decrease bacteria on skin
  • Warnings

    For external use only, do not ingest.

  • Do Not Use

    • If you are allergic to any of the ingredients
    • In or near the eyes
    • On children under 2 years of age
  • Ask a doctor before use if you have

    • Deep or puncture wounds
    • Serious burns
  • Stop use and ask a doctor if

    • Irritation, swelling, pain or other symptoms develop
  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    1. Apply gel to tip of Cleansing Wand
    2. Insert tip with gel into nostril, rotating it in each direction several times
    3. Wipe any excess gel from nose with a tissue
  • DOSAGE & ADMINISTRATION

    • Use every 4-8 hours as needed
    • Children under age 12 use with adult supervision
  • Other Information

    Protect from excessive heat (temperatures about 104°F/40°C)

  • Inactive Ingredients - 81900-013

    Carbomer, Diethylene Glycol Monoethyl Ether, Glycerin, Propylene Glycol, Triethanolamine, Water

  • Inactive Ingredients - 81900-014

    Carbomer, Diethylene Glycol Monoethyl Ether, Glycerin, Peppermint Oil, Propylene Glycol, Triethanolamine, Water

  • Questions?

    Call 1-844-4MY-NASO

    OR (1-844-469-6276)

    M-F 9am to 5pm PST

    NasoClenz.com

  • Principal Display Panel - 81900-013

    Drug Facts

  • Principal Display Panel - 81900-014

    Drug Facts

  • INGREDIENTS AND APPEARANCE
    NASOCLENZ 
    benzalkonium chloride 0.13% gel
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81900-014
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE1.19 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
    TROLAMINE (UNII: 9O3K93S3TK)  
    CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: F68VH75CJC)  
    PEPPERMINT OIL (UNII: AV092KU4JH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:81900-014-031 in 1 BOX09/25/2023
    112 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
    2NDC:81900-014-042 in 1 BOX09/25/2023
    21 in 1 POUCH
    21 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
    3NDC:81900-014-054 in 1 BOX09/25/2023
    31 in 1 POUCH
    31 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
    4NDC:81900-014-061 in 1 BOX02/16/2024
    45 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)09/25/2023
    NASOCLENZ 
    benzalkonium chloride 0.13% gel
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81900-013
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE1.19 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    TROLAMINE (UNII: 9O3K93S3TK)  
    CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: F68VH75CJC)  
    DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:81900-013-031 in 1 BOX07/15/2022
    112 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
    2NDC:81900-013-042 in 1 BOX07/15/2022
    21 in 1 POUCH
    21 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
    3NDC:81900-013-054 in 1 BOX07/15/2022
    31 in 1 POUCH
    31 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
    4NDC:81900-013-6060 in 1 BOX11/15/2022
    41 in 1 POUCH
    41 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
    5NDC:81900-013-0140 in 1 BOX11/01/2021
    51 in 1 POUCH
    51 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
    6NDC:81900-013-028 in 1 BOX11/01/2021
    61 in 1 POUCH
    61 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
    7NDC:81900-013-061 in 1 BOX02/16/2024
    75 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)11/01/2021
    Labeler - Silicon Valley Innovations, Inc. (118048729)
    Registrant - Silicon Valley Innovations, Inc. (118048729)
    Establishment
    NameAddressID/FEIBusiness Operations
    Silicon Valley Innovations, Inc.118048729label(81900-013, 81900-014) , pack(81900-013, 81900-014)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!